ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1119

Prediction of MRI-Detected Cartilage Loss Over 30 Months Using Simplified Radiographic and Clinical Stratification: The MOST Study

Frank Roemer1, David T. Felson2, Jingbo Niu3, Yuqing Zhang2, Michael C. Nevitt4, Michel Crema5, Cora E. Lewis6, James Torner7 and Ali Guermazi5, 1Klinikum Augsburg, Augsburg, Germany, 2Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 3Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 4Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 5Boston University, Boston, MA, 6Preventive Medicine, University of Alabama, Birmingham, Birmingham, AL, 7Epidemiology, University of Iowa, Iowa City, Iowa City, IA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cartilage, imaging techniques, Magnetic resonance imaging (MRI), osteoarthritis and risk assessment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose:

MRI-detected cartilage loss is the main structural outcome measure in large studies of knee OA. Definition of subjects at high risk for cartilage loss is important as this subgroup is likely to benefit most from interventional efforts and will potentially reduce subject numbers and duration of clinical trials. A simple stratification strategy is needed for pre-selecting subjects at high risk. We assessed a set of potential factors in regard to their predictive capability of cartilage loss over 30 months.

Methods:

The Multicenter Osteoarthritis (MOST) Study is a longitudinal study of subjects with knee OA or at risk of OA. 1.0 T MRI was performed at baseline and 30 months follow-up in subjects with radiographic knee OA at baseline. MRIs were assessed according to the WORMS scoring system including within-grade assessment. Altogether 10 tibiofemoral subregions were scored. Cartilage loss was defined as at least within-grade increase in cartilage score in >1, ≥2, or ≥3 subregions. Analyses were repeated with cartilage loss defined as full grade increase. Six predictors that are commonly acquired in screening efforts, i.e., gender, age, BMI, Kellgren Lawrence (K-L) grade (0-1, 2, 3-4), joint effusion (0-1, 2-3) and knee pain (pain on most days during the past 30 days or maximal WOMAC pain score as 0, 1-2, 3-4) were assessed using a 10-fold cross-validation method. The cross-validation was repeated 10 times, and averaged receiver operating characteristics (ROC) curve, i.e., C-statistic, was calculated as a measure of the overall performance. Age and sex were forced in all models. We plotted the ROC curves for each variable selected in the final model according to cross-validation method.

Results:

Of 544 knees randomly selected from the progression cohort, risk of at least within-grade cartilage loss occurring in ≥1, or ≥2, or ≥3 subregions was 53.6%, 31.6%, and 18.1%, respectively. The model containing age, sex, K-L grade, effusion, and knee pain provided the highest prediction accuracy (C-statistic 0.533) for any cartilage loss occurring in at least one subregion. The best models for prediction of at least within-grade cartilage loss of ≥2 or ≥3 included the same variables, i.e., age, sex, K-L grade and knee pain (C-statistics=0.561 for ≥2, and 0.571 for ≥3 subregions). Risk of full-grade cartilage loss in ≥1, ≥2, or ≥3 subregions was 38.8%, 18.8% and 9.7%, respectively. The same variables were included for predicting cartilage loss of a full grade in ≥1, or ≥2, or ≥3 subregions as those for at least within-grade loss. The corresponding C-statistics were 0.559, 0.599, and 0.615 (Figure 1), respectively.

Conclusion:

Among knees with radiographic OA, age, sex, K-L grade and knee pain only had the moderate capability of predicting cartilage loss. Of them the strongest predictors were baseline K-L grade, followed by knee pain. The prediction accuracy of this model needs to be further validated using large databases from other populations.


Disclosure:

F. Roemer,

Boston Imaging Core Lab,

1,

National Institute of Health,

5,

Merck Serono,

5;

D. T. Felson,
None;

J. Niu,
None;

Y. Zhang,
None;

M. C. Nevitt,
None;

M. Crema,

Shareholder Boston Imaging Core Lab, LLC,

1;

C. E. Lewis,
None;

J. Torner,
None;

A. Guermazi,

Boston Imaging Core Lab,

1,

Stryker,

5,

Merck Serono,

5,

Genzyme Corporation,

5,

AstraZeneca,

5,

Novartis Pharmaceutical Corporation,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prediction-of-mri-detected-cartilage-loss-over-30-months-using-simplified-radiographic-and-clinical-stratification-the-most-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology